Skip to content

Quantitative Analysis of Global Proteome in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture

Collection of Bone Specimens for Quantitative Analysis of Global Proteome and Iron Content Detection

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03428672
Enrollment
100
Registered
2018-02-12
Start date
2018-04-01
Completion date
2019-05-01
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fractures

Brief summary

RATIONALE: Collecting and storing bone samples from patients with osteoporotic and nonosteoporotic fracture to quantitatively analyze the differentially expressed proteins to further explain the relationship between bone iron content and bone mineral density (BMD). PURPOSE: This research study is looking at changes of iron content and differentially expressed proteins in bone samples from patients with osteoporotic and nonosteoporotic. fracture.

Detailed description

OBJECTIVES: 1. Establish the iron content in bone specimen in patients with hip fracture. 2. Explore the correlation of BMD and differentially expressed proteins. OUTLINE: 1. Collect human bone specimens from patients with osteoporotic and nonosteoporotic Fracture. 2. Provide a repository for storage of tissue and make these specimens available for approved projects by laboratory-based investigators. 3. Collect clinical data on these patients including bone mineral density. 4. To examine the bone iron content using ICP/MS. 5. Investigate the differentially expressed proteins through quantitative analysing the global proteome of osteoporotic and nonosteoporotic fracture bone specimens.

Interventions

PROCEDUREtotal hip arthroplasty

Bone samples from Hip fracture were collected from the femoral head which has been replaced

Sponsors

Second Affiliated Hospital of Soochow University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
55 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Ages Eligible for Study: 55-90 Years 2. Genders Eligible for Study: Woman 3. Accepts Healthy Volunteers: NO 4. Study Population: Female patients with hip fracture.

Exclusion criteria

1. Malignancy or benign ovarian cysts 2. Known chronic or systemic diseases 3. Hormone therapy in the previous 3 months 4. Bone metabolism and drug therapy

Design outcomes

Primary

MeasureTime frameDescription
the iron content in human bone samples3 monthBone samples were preprocess and decomposed by microwave.Icp-ms is used for quantitative detection of samples.

Secondary

MeasureTime frameDescription
The value of bone mineral densityone weekBone mineral density was measured by double energy X-ray absorptiometer (DXA) in a week before surgery.
Quantitative Analysis of Global Proteome in bone samples5 monthFind the differentially expressed proteins in nonosteoporotic or osteoporotic bone sample through using an integrated approach involving TMT labeling and LC-MS/MS to quantify the dynamic changes of the whole proteome of Human Species.

Countries

China

Contacts

Primary ContactYoujia Xu, PhD
xuyoujia@suda.edu.cn86-0512-67783346
Backup ContactFan Yang, MSc
1066276684@qq.com86-0512-67784115

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026